US 12,109,103 B2
Methods and devices for treating sphincter disorders
Robert A. Ganz, Minnetonka, MN (US); Gabriel L. Ganz, Minnetonka, MN (US); Ryan Timothy Balko, Rogers, MN (US); Justin James Herbert, Osseo, MN (US); and Brett Allyn Williams, North Oaks, MN (US)
Assigned to ESCHARA MEDICAL, LLC, Minnetonka, MN (US)
Filed by ESCHARA MEDICAL, LLC, Minnetonka, MN (US)
Filed on Jan. 4, 2024, as Appl. No. 18/404,655.
Application 18/404,655 is a continuation of application No. 17/652,628, filed on Feb. 25, 2022.
Application 17/652,628 is a continuation of application No. PCT/US2020/047831, filed on Aug. 25, 2020.
Claims priority of provisional application 62/891,803, filed on Aug. 26, 2019.
Claims priority of provisional application 62/895,306, filed on Sep. 3, 2019.
Claims priority of provisional application 62/932,260, filed on Nov. 7, 2019.
Claims priority of provisional application 62/978,083, filed on Feb. 18, 2020.
Prior Publication US 2024/0138971 A1, May 2, 2024
Int. Cl. A61F 2/04 (2013.01)
CPC A61F 2/04 (2013.01) [A61F 2002/044 (2013.01); A61F 2210/0004 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A bioabsorbable scaffold, comprising:
a matrix comprising:
a first bioabsorbable filament; and
a second bioabsorbable filament,
wherein the matrix is configured to be disposed at least partially around a body portion or a sphincter of a patient,
wherein the matrix is configured to induce a formation of collagen tissue about a portion of the sphincter,
wherein the first bioabsorbable filament has a first bioabsorption rate and the second bioabsorbable filament has a second bioabsorption rate that is different from the first bioabsorption rate, and
wherein the matrix is configured to couple the body portion or the sphincter of the patient to an adjacent body portion.